Identification,characterization and targeting of Docetaxel-resistant prostate cancer cells
基本信息来源于合作网站,原文需代理用户跳转至来源网站获取
摘要:
Men with castration-resistant prostate cancer exhibit resistance to chemotherapeutic agents such as Docetaxel.Defining the mechanisms of resistance to Docetaxel is critical for treating advanced disease.In a new study,Carlos Cordon-Cardo and colleagues determine that Docetaxel-resistant prostate cancer cells rely on the Notch and Hedgehog signaling pathways for their survival.These findings provide a rationale for the inhibition of Notch and Hedgehog pathways in Docetaxel-resistant prostate cancer.The authors demonstrate that Docetaxelresistant cells can propagate tumors and may exist prior to treatment,suggesting that Notch/Hedgehog pathway inhibition in combination with Docetaxel may prevent treatment-resistance.